Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital
<p>Abstract</p> <p>Background</p> <p>Community-acquired pneumonia (CAP) is a common cause of pediatric admission to hospital. The objectives of this study were twofold: 1) to describe the clinical characteristics of CAP in children admitted to a tertiary care pediatric...
Saved in:
Main Authors: | Rowan-Legg Anne (Author), Barrowman Nicholas (Author), Shenouda Nazih (Author), Koujok Khaldoun (Author), Le Saux Nicole (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
by: Sandra Rodrigues da Silva, et al. -
Clinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine
by: Lima EJF, et al.
Published: (2015) -
Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
by: Gili Regev-Yochay, et al.
Published: (2018) -
The effectiveness of 13-valent pneumococcal vaccine against community acquired pneumonia in young children: a systematic review and meta-analysis
by: Ninel Revenco, et al.
Published: (2022) -
Preventive effects of 23-valent pneumococcal polysaccharide vaccine on community-acquired pneumonia hospitalization in older individuals in China: A case-control study
by: Na Liu, et al.
Published: (2024)